$RLFTF (Covid-19) NeuroRx and Relief announce topl
Post# of 144503
(Total Views: 101)
Posted On: 10/13/2020 2:02:23 AM
$RLFTF (Covid-19) NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100™ (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to
https://relieftherapeutics.com/neurorx-and-re...elated-to/
https://relieftherapeutics.com/neurorx-and-re...elated-to/
(0)
(0)
$MJ
Scroll down for more posts ▼